Experience of use of vaccination against pneumococcal infection (Prevenar 13) in patients with chronic non-specific diseases in the Republic of Sakha (Yakutia)


DOI: https://dx.doi.org/10.18565/therapy.2023.6.132-137

Argunova A.N., Emelyanova E.A.

Medical Institute of M.K. Ammosov North-Eastern Federal University, Yakutsk
Abstract. Streptococcus pneumonia remains the leading causative agent of community-acquired pneumonia and other respiratory infections in adult patients, including those who are in risk groups for complications and death from pneumonia. According to the position of WHO and other major medical communities, vaccination against pneumococcal infection should be included in the national vaccination schedules for the above-mentioned category of people. Article presents the data concerning the influence of vaccination against pneumococcal infection using the Prevenar 13 vaccine at the risks of developing pneumonia, exacerbation of chronic non-specific lung diseases and decompensation of chronic non-infectious diseases in the risk group among the adult population of the Republic of Sakha (Yakutia).
Keywords: pneumococcal polysaccharide conjugate vaccine (thirteen-valent), vaccination against pneumococcal infection, prevention of pneumococcal infections, pneumonia
Read entire article

Literature

1. Росстат. Здравоохранение в России. 2021. Статистический сборник. М. 2021; 171 с. Доступ:https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf (дата обращения – 01.08.2023). [Federal State Statistics Service (Russia). Healthcare in Russia. 2021. Statistical compendium. Moscow. 2021; 171 pp.URL: https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf (date of access – 01.08.2023) (In Russ.)].


2. Mylotte J.M. Nursing home-acquired pneumonia: Update on treatment option. Drugs Aging. 2006; 23(5): 377–90.https://dx.doi.org/10.2165/00002512-200623050-00002.


3. World Health Organization (WHO) statistics. Mortality database. (No. of deaths, pneumonia, both sexes, ages 1–74 years; 0101 Russian Federation, 2009). URL: http://www.who.int/healthinfo/statistics/mortality_rawdata/en (date of access – 01.08.2023).


4. Bewick T., Sheppard C., Greenwood S. et al. Serotype prevalence in adults hospitalized with pneumococcal non-invasive community-acquired pneumonia. Thorax. 2012; 67(6): 540–45. https://dx.doi.org/10.1136/thoraxjnl-2011-201092.


5. ГБУ РС(Я) «Якутский республиканский медицинский информационно-аналитический центр». Медицинская статистика. 2020 г. Доступ: https://yakmed.ru/#/function/catalogMedstat (дата обращения – 01.08.2023). [Yakut Republican Medical Information and Analytical Center. Medical statistics. 2020.URL: https://yakmed.ru/#/function/catalogMedstat (date of access – 01.08.2023) (In Russ.)].


6. Musher D.M., Rueda A.M., Kaka A.S., Mapara S.M. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 2007; 45(2): 158–65. https://dx.doi.org/10.1086/518849.


7. World Health Organization. Considerations for pneumococcal vaccination in older adults. 2021. URL: https://apps.who.int/iris/bitstream/handle/10665/341722/WER9623-217-228-eng-fre.pdf?sequence=1&isAllowed=y (date of access – 01.08.2023).


8. Center for Disease Control and Prevention. Pneumococcal Vaccination.URL: https://www.cdc.gov/pneumococcal/vaccination.html (date of access – 01.08.2023).


9. Лобзин Ю.В., Сидоренко С.В., Харит С.М. с соавт. Серотипы Streptococcus Pneumonia, вызывающие ведущие нозологические формы пневмококковых инфекций. Журнал инфектологии. 2013; 5(4): 36–42. [Lobzin Yu.V., Sidorenko S.V., Kharit S.M. et al. Serotypes of Streptococcus Pneumoniae causing major pneumococcal infections. Zhurnal infektologii = Journal of Infectology. 2013; 5(4): 36–42 (In Russ.)]. EDN: RPRKPP.


10. Сведения о контингентах детей и взрослых, привитых против инфекционных заболеваний (форма № 6). Доступ:https://www.consultant.ru/document/cons_doc_LAW_52009/0282471a4eefb3ae398a61d683147ce685f9057f/ (дата обращения – 01.08.2023). [Information on the contingents of children and adults vaccinated against infectious diseases (form No. 6).URL: https://www.consultant.ru/document/cons_doc_LAW_52009/0282471a4eefb3ae398a61d683147ce685f9057f/ (date of access – 01.08.2023).


11. Аргунова А.Н., Бондарева Ж.В., Прокопьев Е. С., Носихина О.М. Анализ динамики заболеваемости и факторов влияния на развитие пневмококковых инфекций у взрослого населения в Республике Саха (Якутия). Эпидемиология и вакцинопрофилактика. 2018; 17(4): 38–45. [Argunova A.N., Bondareva Zh.V., Prokopiev E.S., Nosikhina O.M. Analysis of morbidity dynamics and factors influencing the development of pneumococcal infections among the adult population of the Sakha Republic (Yakutia). Epidemiologiya i vaktsinoprofilaktika = Epidemiology and Vaccinal Prevention. 2018; 17(4): 38–45 (In Russ.)].https://dx.doi.org/10.31631/2073-3046-2018-4-38-45. EDN: UXOSFG.


About the Autors

Agrafena N. Argunova, PhD in Medical Sciences, associate professor, head of the Department «Hospital therapy, occupational diseases and clinical pharmacology» of the Medical institute, M.K. Ammosov North-Eastern Federal University. Address: 677000, Yakutsk, 58 Belinskogo Str.
E-mail: agrafena888@mail.ru
Elvira A. Emelyanova, PhD in Medical Sciences, associate professor of the Department «Hospital therapy, occupational diseases and clinical pharmacology» of the Medical institute, M.K. Ammosov North-Eastern Federal University. Address: 677000, Yakutsk, 58 Belinskogo Str.
E-mail: elviraemelyanova03@mail.ru


Similar Articles

Back to Content

Бионика Медиа